OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next?

FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials

Evis Sala Announces a Landmark Oncology Partnership Between Albania and Italy

First Chemotherapy Session: What to Expect

Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma

RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer

Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine

SABCS 2026 Male Breast Cancer Advocate Scholarship

Calculators

MASCC Risk Index Calculator (Febrile Neutropenia)

Identifies low-risk febrile neutropenia patients using the MASCC (Multinational Association for Supportive Care in Cancer) risk index.

Check if YES (0 points), leave unchecked if NO (+5 points)

Check if YES (0 points), leave unchecked if NO (+4 points)

Check if YES (0 points), leave unchecked if NO (+3 points)

Check if YES (+3 points), leave unchecked if NO (0 points)

Check if YES (+2 points), leave unchecked if NO (0 points)

MASCC Risk Index Scoring:

  • Burden of illness: No/mild = 5, Moderate = 3, Severe = 0
  • No hypotension: +5 points
  • No COPD: +4 points
  • No dehydration: +3 points
  • Solid tumor/no fungal infection: +4 points
  • Outpatient at onset: +3 points
  • Age <60 years: +2 points

Risk Classification:

  • Low risk: ≥21 points (suitable for outpatient management)
  • High risk: <21 points (requires inpatient management)